Outcome of Colonoscopy Screening and Surveillance
Data Collection
Collected from today forward - ProspectiveCohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: September 1, 2011
Actual date on which the first participant was enrolled.Investigator's goal is to collect data from the endoscopy reports and clinic station reports to complete a descriptive analysis of the demographics, colonoscopy procedure performance, and assess the type of benign colon polyps detected during screening and surveillance from 02/01/2000 - 12/31/2020. Specific variable to be reviewed: Patient Demographics: Age, Sex, Race, Height, Weight, BMI (patient privacy will be acknowledged). Indications for Colonoscopy (screening, surveillance, symptoms or tertiary referral [EMR]) Comorbid conditions: , cancer and surgical history, medical conditions, Colonoscopy procedure; quality of colon preparation (using the Boston Bowel Preparation Scale) 0 - 3 for each section of the colon (Ascending, Transverse, Descending and Total Colon) , cecal intubation rate, cecal intubation and total procedure time, type of colonoscope (if CO2 was used in the procedure and techniques for colonoscope insertion, including position changes. Examination findings: number of polyps and nature of polyps removed (site, size, surface, vascular pattern); type of polyp removed (serrated and sessile (flat) ; optical features and histology of polyps. Resection techniques: biopsy, snare resection, endoscopic mucosal resection etc. Including Pathology report findings so that a comparison can be made of the optical features and actual pathology report. Outcomes of colonoscopy: adenoma detections (tubular and villous), cancer and quality metrics. Outcome of colonoscopy: Complications (Bleeding and performance).
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.5000 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
University of Texas MD Anderson Cancer Center
Houston, United StatesOpen University of Texas MD Anderson Cancer Center in Google Maps